|
January 2017
|
Jim Evans, M.D., Ph.D.
The University of North Carolina at Chapel Hill |
Cancer Prevention, Genomics, and the PMI |
|
January 2017
|
Andrew Briggs, D.Phil., M.Sc.
University of Glasgow |
Designing a value framework for oncology: what are the issues with existing frameworks and can we do better? |
|
January 2017
|
Shiriki K. Kumanyika, Ph.D., M.P.H.
University of Pennsylvania |
Obesity, Cancer Prevention, and Health Equity. The Promise of Public Health Approaches |
|
January 2017
|
Victoria L. Champion, Ph.D., R.N., F.A.A.N.
Indiana University Simon Cancer Center |
How do I develop a program of Cancer Control Science that will make a difference? |
|
December 2016
|
Sudhir Srivastava, Ph.D., M.P.H., M.S.
NCI Division of Cancer Prevention |
My Journey to Cancer Biomarker Research: Building a Translational Science Infrastructure - It Takes a Village |
|
November 2016
|
Valerie M. Weaver, Ph.D.
University of California San Francisco |
Force and Breast Cancer Risk |
|
October 2016
|
Susan E. Olivo-Marston, Ph.D., M.P.H.
The Ohio State University |
Obesity and Colon Cancer…Does Timing Matter?” |
|
October 2016
|
Erin Kent, Ph.D., M.S.
National Cancer Institute |
Moving from Patient- to Family-Centric: Progress and Remaining Challenges in Cancer Caregiving |
|
October 2016
|
Alan G. Nyitray, Ph.D.
National Cancer Institute |
The Epidemiology of Anal HPV in High Risk Men and Novel Opportunities for Anal Cancer Screening |
|
September 2016
|
Elizabeth A. Platz, Sc.D., M.P.H.
John Hopkins Bloomberg School of Public Health |
Enhancing the Infrastructure of a Cardiovascular Disease Cohort for Cancer Edpidemiology Research: Efforts, Findings, and Opportunities |
